CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,189
-7.3%
19,0780.0%0.00%
Q2 2023$31,479
-89.4%
19,078
-74.5%
0.00%
Q2 2021$297,000
-67.0%
74,757
-56.7%
0.00%
Q1 2021$899,000
-7.2%
172,697
-4.6%
0.00%
Q4 2020$969,000
+10.1%
181,1100.0%0.00%
Q3 2020$880,000
+235.9%
181,110
+236.0%
0.00%
Q2 2020$262,000
+61.7%
53,908
+130.6%
0.00%
Q1 2019$162,00023,3790.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 11,503,294$55,848,00077.67%
Bracebridge Capital, LLC 428,571$2,083,0000.33%
Oak Grove Capital LLC 89,000$432,0000.20%
Perceptive Advisors 1,750,000$8,496,0000.12%
Virtu Financial LLC 117,206$569,0000.10%
WEDBUSH SECURITIES INC 103,240$501,0000.05%
J. Goldman & Co LP 117,600$571,0000.04%
Engineers Gate Manager LP 68,300$332,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 118,900$577,0000.01%
Brandywine Global Investment Management, LLC 137,029$666,0000.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders